Your session is about to expire
← Back to Search
Behavioral Intervention
sipIT for Kidney Stones
N/A
Recruiting
Research Sponsored by Penn State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age 18 or older
Previous diagnosis of symptomatic kidney stone in the past 5 years
Must not have
Co-morbidities that preclude high fluid intake (congestive heart failure, end-stage renal disease, chronic hyponatremia)
Plan to have surgery in the next 6 months
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from the end of the intervention period (3 months) to the maintenance change at 6 months
Awards & highlights
No Placebo-Only Group
Summary
This trial studies how a system that tracks fluid intake and sends reminders can help patients change and maintain their drinking habits, especially when their routines are disrupted by stress or life events.
Who is the study for?
This trial is for individuals who are currently experiencing kidney stones. The specific eligibility criteria to participate in the study have not been provided, so it's important to contact the research team for detailed information on who can join.
What is being tested?
The sipIT intervention is being tested in this study. It aims to understand how behavior changes, continues over time, and adherence are influenced during and after a three-month period of using sipIT.
What are the potential side effects?
Potential side effects of the sipIT intervention are not specified here. Participants interested should inquire with the research team about any risks or adverse reactions associated with this intervention.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Select...
I have had a painful kidney stone in the last 5 years.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I do not have heart failure, severe kidney disease, or chronic low sodium that would stop me from drinking a lot of fluids.
Select...
I am planning to undergo surgery within the next 6 months.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ from the end of the intervention period (3 months) to the maintenance change at 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from the end of the intervention period (3 months) to the maintenance change at 6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Urine volume (intervention)
Secondary study objectives
Urine volume (maintenance)
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: sipITExperimental Treatment1 Intervention
Participants will receive an educational handout about physical activity, a connected water bottle with its companion mobile application. For months 1-3, participants will receive lapse-contingent reminders to drink delivered by text message.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for kidney stones include increased fluid intake, dietary modifications, and medications. Increased fluid intake helps dilute the substances in urine that lead to stones, reducing the risk of stone formation.
Dietary modifications, such as reducing salt and animal protein intake, help decrease the concentration of stone-forming minerals. Medications like thiazide diuretics reduce calcium levels in urine, while citrate supplements can prevent stone formation by binding with calcium.
These treatments are crucial for kidney stone patients as they address the root causes of stone formation, thereby preventing recurrence and reducing the need for surgical interventions.
Metabolic risk-evaluation and prevention of recurrence in stone disease: does it make sense?
Metabolic risk-evaluation and prevention of recurrence in stone disease: does it make sense?
Find a Location
Who is running the clinical trial?
Penn State UniversityLead Sponsor
369 Previous Clinical Trials
127,442 Total Patients Enrolled
2 Trials studying Kidney Stones
3,439 Patients Enrolled for Kidney Stones